Rubio J C, Martín M A, del Hoyo P, de Bustos F, Campos Y, Arenas J
Centro de Investigación, Hospital Universitario 12 de Octubre, Madrid, España.
Rev Neurol. 1998 Apr;26 Suppl 1:S15-20.
The mitochondrial respiratory chain is the final step in oxidative metabolism and plays an essential part in the mechanisms of energy production. It is composed of five enzymatic complexes under the dual control of nuclear and mitochondrial genomes. The disorders caused by respiratory chain defects are heterogeneous, mainly affecting organs and tissues which are functionally dependent on oxidative metabolism, such as brain, muscle, myocardium, kidney and liver. The activity of the enzymatic complexes may be measured in any tissue or organ, but skeletal muscle is usually used since it is post-mitotic and permits correlation with morphological studies. Defects in the electron transport chain may affect one or more complexes. Monoenzymopathies are characteristic of nuclear alterations, particularly if there is phenotype histo-specificity. However, mutations of the structural genes of the mitochondrial DNA (mtDNA) may also produce specific defects. Combined defects are characteristic of mtDNA alterations due to reduced synthesis of mitochondrial proteins.
线粒体呼吸链是氧化代谢的最后一步,在能量产生机制中起着至关重要的作用。它由五个酶复合物组成,受核基因组和线粒体基因组的双重控制。呼吸链缺陷引起的疾病具有异质性,主要影响功能上依赖氧化代谢的器官和组织,如脑、肌肉、心肌、肾脏和肝脏。酶复合物的活性可以在任何组织或器官中测量,但通常使用骨骼肌,因为它是有丝分裂后的,并且可以与形态学研究相关联。电子传递链中的缺陷可能影响一个或多个复合物。单酶病是核改变的特征,特别是如果存在表型组织特异性。然而,线粒体DNA(mtDNA)结构基因的突变也可能产生特定的缺陷。由于线粒体蛋白合成减少,联合缺陷是mtDNA改变的特征。